MALAT1 and breast cancer: To explore whether the expressions of MALAT1 in triple negative and Her-2 positive breast cancers were correlated to patients’ prognostic factors, preliminary experiments were designed and the expressions of MALAT1 in samples were detected by qRT-PCR.